^
2d
Sinonasal DICER1‑mutated embryonal-like (botryoid-like) rhabdomyosarcoma in an adult: report of the first case. (PubMed, Virchows Arch)
Notably, the presence of cartilage foci within a RMS-like neoplasm represents a strong clue to an underlining DICER1 alteration. The rarity of this presentation in the nasal fossa at this age, coupled with its implications for diagnosis, treatment, and familial screening, emphasizes the need for awareness of the morphology patterns of DICER1-associated neoplasms across diverse anatomical sites.
Journal
|
KRAS (KRAS proto-oncogene GTPase) • DICER1 (Dicer 1 Ribonuclease III) • MYOD1 (Myogenic Differentiation 1) • PAX3 (Paired Box 3)
|
KRAS mutation
8d
A Diagnostic Pitfall: Retrocaval Nerve Sheath Tumor. (PubMed, Cureus)
Immunohistochemical staining, crucial for characterizing soft-tissue tumor differentiation, revealed diffuse positivity for SOX10 and S100 protein, consistent with a primary nerve sheath tumor rather than metastatic disease. This case highlights the diagnostic challenge posed by FDG-avid lesions in patients with a history of malignancy, underscoring the importance of considering rare differential diagnoses and pursuing tissue diagnosis when imaging is equivocal or clinical presentation deviates from expected metastatic behavior.
Journal
|
CEACAM5 (CEA Cell Adhesion Molecule 5) • SOX10 (SRY-Box 10)
11d
An ALK-Positive Epithelioid Fibrous Histiocytoma with Superficial ALK-Rearranged Myxoid Spindle Cell Neoplasms-Like Features and Foamy Histiocyte Infiltration: Report of a Challenging Case. (PubMed, Turk Patoloji Derg)
This case presents the diagnostic challenges in ALK-positive neoplasms. Superficial soft tissue tumors associated with ALK include a heterogeneous group of lesions that may share similar morphological features. We believe that a generic term, ALK-Rearranged Superficial Mesenchymal Neoplasms (ARSMN), may serve as a more inclusive diagnostic label for these entities in routine pathology practice.
Journal
|
ALK (Anaplastic lymphoma kinase)
|
ALK positive • ALK rearrangement
15d
Mesoblastic nephroma in a young Entlebucher Mountain Dog. (PubMed, J Comp Pathol)
The expression of p75NTR has not been described in this tumour entity before and its significance with regard to tumour promoting or tumour suppressing function or indication of a neurogenic differentiation remains undetermined. After a 3-year follow-up the dog was clinically healthy, indicating a successful surgical treatment.
Journal
|
VIM (Vimentin) • NGFR (Nerve Growth Factor Receptor)
16d
Proliferative Nodule With Unusual Features in a Giant Congenital Melanocytic Nevus. (PubMed, Pediatr Dermatol)
However, genetic sequencing identified the NRAS Q16R mutation both in the nodule and underlying congenital nevus, leading to the diagnosis of a proliferative nodule composed of poorly differentiated melanocytes. Despite the limited use of molecular biology in the diagnosis of atypical proliferative nodules, it may be helpful in some challenging cases.
Journal
|
NRAS (Neuroblastoma RAS viral oncogene homolog)
|
NRAS mutation
18d
Lipoblastoma-Like Tumor: A Case Report From Costa Rica. (PubMed, Cureus)
LLTs should be considered in the differential diagnosis of vulvar soft tissue masses. Accurate histopathological and molecular evaluation, combined with appropriate surgical management, ensures favorable outcomes and helps avoid unnecessary interventions.
Journal
|
CD34 (CD34 molecule) • DDIT3 (DNA-damage-inducible transcript 3) • PLAG1 (PLAG1 Zinc Finger)
18d
Anaplastic lymphoma kinase-negative inflammatory myofibroblastic tumor of the appendix and ileocecal region: a rare clinical entity. (PubMed, J Surg Case Rep)
Surgical resection remains the mainstay of treatment. This case highlights the importance of including IMT in the differential diagnosis of atypical intra-abdominal masses and supports the role of advanced molecular techniques in improving diagnostic accuracy and management.
Journal
|
ALK (Anaplastic lymphoma kinase)
|
ALK negative
21d
A Distinct Subtype of Uterine Sarcoma: Case Report of a High-Grade Uterine Sarcoma With Myogenic Differentiation Harboring a PDGFRB Hotspot Mutation. (PubMed, Int J Surg Pathol)
Their aggressive clinical behavior, combined with unique histopathological and genetic features, underscores the need for molecular testing to ensure accurate diagnosis. Tyrosine kinase inhibitors such as imatinib may hold therapeutic promise, but further research is needed to optimize treatment strategies.
Journal
|
ER (Estrogen receptor) • ALK (Anaplastic lymphoma kinase) • TP53 (Tumor protein P53) • PGR (Progesterone receptor) • PDGFRB (Platelet Derived Growth Factor Receptor Beta) • NOTCH3 (Notch Receptor 3) • MYOD1 (Myogenic Differentiation 1)
|
TP53 mutation
|
imatinib
21d
Malignant high-grade unclassifiable spindle cell sarcoma in the hand: A diagnostic and therapeutic challenge. (PubMed, JPRAS Open)
A meticulous surgical approach is vital for the management of the balance of complete tumor excision and preservation of hand function. A thorough histopathological examination is necessary for diagnosis. Collaboration across disciplines is key to improving treatment outcomes.
Journal
|
CD34 (CD34 molecule) • NCAM1 (Neural cell adhesion molecule 1) • SOX10 (SRY-Box 10) • CD99 (CD99 Molecule) • SS18 (SS18 Subunit Of BAF Chromatin Remodeling Complex)
22d
TRAF7-Mutated Myxoid and Spindle Cell Mesenchymal Tumor Occurring in a Pediatric Patient in the Post-Transplant Setting: Expanding the Spectrum of TRAF7-Mutated Tumors. (PubMed, Genes Chromosomes Cancer)
The tumor was resected, and the patient remains stable at 7 months follow-up. This report is the first known case of a TRAF7-mutated myxoid and spindle cell tumor in a pediatric patient.
Journal
|
CD34 (CD34 molecule)
22d
Prevalence of Histological Transformation in First-Line Osimertinib Non-Small Cell Lung Cancers: Case Series and Literature Review. (PubMed, Int J Mol Sci)
Despite the usefulness of liquid biopsy, rebiopsy should be executed whenever possible. Indeed, it remains the only tool for assessing histological transformation, which greatly impacts prognosis and treatment decisions.
Journal
|
EGFR (Epidermal growth factor receptor) • TP53 (Tumor protein P53) • MET (MET proto-oncogene, receptor tyrosine kinase)
|
TP53 mutation • EGFR mutation • EGFR L858R • EGFR exon 19 deletion • MET amplification • EGFR positive
|
Tagrisso (osimertinib)
22d
ZEB1 and Uveal Melanoma Invasiveness. (PubMed, Int J Mol Sci)
Effects of siRNA-dependent ZEB1 knockdown on UM cell proliferation and their sensitivity to the VEGF-A inhibitor Eylea (aflibercept) were tested by MTT and in a real-time proliferation assay...In addition, there is probably a ZEB1 feedback loop that is sensitive to a drop in VEGF-A concentration. The data obtained allow us to consider ZEB1 silencing as an auxiliary link for a combined strategy of killing UM cells.
Journal
|
KDR (Kinase insert domain receptor) • ZEB1 (Zinc Finger E-box Binding Homeobox 1)